Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMO | O15229 | 16/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ASPH | Q12797 | 2/20 | 0.50 |
| ▸ | KDM8 | Q8N371 | 2/20 | 0.50 |
| ▸ | KDM6B | O15054 | 1/20 | 0.50 |
| ▸ | TET3 | O43151 | 1/20 | 0.50 |
| ▸ | KDM4A | O75164 | 1/20 | 0.50 |
| ▸ | BBOX1 | O75936 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.50 |
| ▸ | KDM5A | P29375 | 1/20 | 0.50 |
| ▸ | KDM5C | P41229 | 1/20 | 0.50 |
| ▸ | KDM4D | Q6B0I6 | 1/20 | 0.50 |
| ▸ | TET2 | Q6N021 | 1/20 | 0.50 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.50 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.50 |
| ▸ | TET1 | Q8NFU7 | 1/20 | 0.50 |
| ▸ | EGLN2 | Q96KS0 | 1/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.50 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL3272233 | 0.97 | KMO (0.57) | KMOKDM4EALDH1A1ASPHKDM8 | |
| Hydrochloric Acid SCHEMBL3272369 | 0.97 | KMO (0.57) | KMOKDM4EALDH1A1ASPHKDM8 | |
| Fluoride SCHEMBL21173953 | 0.97 | KMO (0.57) | KMOKDM4EALDH1A1ASPHKDM8 | |
| SCHEMBL17132794 | 0.88 | KMO (0.50) | KMOKDM4EALDH1A1ASPHKDM8 | |
| SCHEMBL15228305 | 0.88 | KMO (0.50) | KMOKDM4EALDH1A1ASPHKDM8 | |
| Pyrimidine SCHEMBL28981669 | 0.86 | KMO (0.59) | KMOKDM4EALDH1A1ASPHKDM8 | |
| SCHEMBL18167352 | 0.85 | KMO (0.52) | KMOKDM4EALDH1A1ASPHKDM8 | |
| SCHEMBL232129 | 0.85 | KMO (0.52) | KMOKDM4EALDH1A1ASPHKDM8 | |
| SCHEMBL14221342 | 0.85 | KMO (0.52) | KMOKDM4EALDH1A1ASPHKDM8 | |
| SCHEMBL19128953 | 0.83 | KMO (0.50) | KMOKDM4EALDH1A1ASPHKDM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 411 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12017186-B2 | Use of polyvinylpyrrolidone in the preparation of ana-ZMOF thin film membranes for separation processes | KING ABDULLAH UNIVERSITY OF SCIENCE & TECHNOLOGY (SA) | 2024-06-25 | — | — | US | claimed |
| CN-113699536-B | Metal phosphide electrocatalyst based on MOF derivation, preparation method and application | 安徽理工大学 | 2022-12-23 | — | — | CN | claimed |
| EP-3512905-B1 | METHOD FOR PRODUCING A POLYBENZAZOL POLYMER (P) | BASF SE (DE) | 2022-08-24 | — | — | EP | claimed |
| CN-109790292-B | Process for preparing polybenzazole polymer (P) | 巴斯夫欧洲公司 | 2022-05-31 | — | — | CN | claimed |
| US-20210394126-A1 | USE OF POLYVINYLPYRROLIDONE IN THE PREPARATION OF ANA-ZMOF THIN FILM MEMBRANES FOR SEPARATION PROCESSES | UNIV KING ABDULLAH SCI & TECH (SA) | 2021-12-23 | — | — | US | claimed |
| CN-113699536-A | Metal phosphide electrocatalyst based on MOF derivation, preparation method and application | 安徽理工大学 | 2021-11-26 | — | — | CN | claimed |
| CN-113667136-A | Ultrahigh-stability and low-cost metal-organic framework material for efficiently separating acetylene/carbon dioxide and preparation method thereof | 浙江大学 | 2021-11-19 | — | — | CN | claimed |
| US-11142826-B2 | Substitution-type electroless gold plating solution containing purine or pyrimidine-based compound having carbonyl oxygen and substitution-type electroless gold plating method using the same | MK CHEM & TECH CO., LTD (KR) | 2021-10-12 | — | — | US | claimed |
| CN-110923680-B | Substituted electroless gold plating solution containing purine or pyrimidine compound having carbonyl oxygen and method using same | MK化学科技有限公司 | 2021-09-24 | — | — | CN | claimed |
| CN-113332958-A | Forming method of nitrogen-containing aluminum-based metal-organic framework material and air water absorption application thereof | 浙江大学 | 2021-09-03 | — | — | CN | claimed |
| WO-2010062573-A1 | SYNTHETIC MIMETICS OF HOST DEFENSE AND USES THEREOF | POLYMEDIX, INC. (US) | 2010-06-03 | — | — | WO | claimed |
| US-20100105703-A1 | Synthetic Mimetics Of Host Defense And Uses Thereof | POLYMEDIX, INC. (US) | 2010-04-29 | — | — | US | claimed |
| EP-1877412-A1 | ZEOLITE-LIKE METAL ORGANIC FRAMEWORKS (ZMOFS): MODULAR APPROACH TO THE SYNTHESIS OF ORGANIC-INORGANIC HYBRID POROUS MATERIALS HAVING A ZEOLITE LIKE TOPOLOGY | UNIVERSITY OF SOUTH FLORIDA (US) | 2008-01-16 | — | — | EP | claimed |
| US-20060287190-A1 | Zeolite-like metal organic frameworks (ZMOFS): modular approach to the synthesis of organic-inorganic hybrid porous materials having a zeolite like topology | UNIVERSITY OF SOUTH FLORIDA | 2006-12-21 | — | — | US | claimed |
| WO-2006116340-A1 | ZEOLITE-LIKE METAL ORGANIC FRAMEWORKS (ZMOFS): MODULAR APPROACH TO THE SYNTHESIS OF ORGANIC-INORGANIC HYBRID POROUS MATERIALS HAVING A ZEOLITE LIKE TOPOLOGY | UNIVERSITY OF SOUTH FLORIDA (US) | 2006-11-02 | — | — | WO | claimed |
| US-6936616-B2 | Pyrimidine matrix metalloproteinase inhibitors | WARNER-LAMBERT COMPANY (US) | 2005-08-30 | — | — | US | claimed |
| JP-2004518723-A | — | — | 2004-06-24 | — | — | JP | claimed |
| EP-1368323-A1 | PYRIMIDINE MATRIX METALLOPROTEINASE INHIBITORS | Warner-Lambert Company LLC (US) | 2003-12-10 | — | — | EP | claimed |
| US-20020151555-A1 | Pyrimidine matrix metalloproteinase inhibitors | BARVIAN NICOLE CHANTEL (US) | 2002-10-17 | — | — | US | claimed |
| WO-2002064571-A1 | PYRIMIDINE MATRIX METALLOPROTEINASE INHIBITORS | WARNER-LAMBERT COMPANY LLC (US) | 2002-08-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100105703-A1 | Synthetic Mimetics Of Host Defense And Uses Thereof | TLR3, MYD88, TLR5 | KMO 2296/4885KDM4E 2532/4885ALDH1A1 4441/4885 |
| US-20020151555-A1 | Pyrimidine matrix metalloproteinase inhibitors | MMP13, MMP3, MMP11 | KMO 1752/4885KDM4E 1484/4885ALDH1A1 624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.